A digital health name must pass trademark review in a crowded medical and pharma category, steer clear of language FDA or FTC could read as an implied clinical claim, and still work when a health system's brand team places your logo beside theirs on a co-branded portal. We create naming and identity systems that hold up with all three audiences – clinical, regulatory, and consumer – rather than one that works only in a pitch deck.
The Challenge
Trademark availability in health and medical categories is much narrower than a founder-led search will uncover
The medical device, pharma, and digital health trademark classes are dense with existing marks, and a name that looks clear on a basic Google or USPTO keyword search often collides with an existing registration once a proper clearance search runs across adjacent classes. Companies that skip a real clearance search and launch anyway sometimes discover the conflict only after a cease-and-desist letter arrives, forcing a rebrand after the name is already on a health system contract or FDA submission.
Names and taglines suggesting a clinical outcome can create FTC and FDA exposure before the product is even launched
Language like "cures," "prevents," or even softer implied-outcome phrasing in a product name or tagline can trigger FTC health-claims scrutiny for a consumer product, or complicate FDA's read of your product category if you're anywhere near a regulated device classification. A name chosen for its marketing punch can quietly become a legal liability the moment a regulator or plaintiff's attorney reads it as a claim rather than a brand.
Your identity must perform in a pitch deck, on a consumer app store page, and within a co-branded health system portal – yet most identity systems are designed for only one
A digital health brand identity built purely for a consumer app store listing often looks unserious next to a health system's own brand when placed on a co-branded patient portal, while an identity built to look clinical and credible for enterprise buyers can undersell a consumer product competing for App Store attention against consumer wellness brands. Building the identity for only one of these contexts means redesigning under deadline pressure the first time the other context shows up in a real deal.
Rebranding after FDA clearance or a significant clinical validation milestone can leave years of brand equity behind if it hasn't been planned for
Companies frequently launch under one name during an unregulated pilot phase, then need to rename or re-position once a product moves through FDA clearance or earns clinical validation that changes what claims it can legitimately make. Without a naming and identity system designed with that trajectory in mind from the start, the eventual rename means abandoning search rankings, sales collateral, and buyer recognition built under the old name, instead of evolving the identity forward.
How We Can Help
We begin with a naming brief shaped around your specific regulatory path and buyer mix – are you currently selling to health systems with a route toward FDA clearance, operating a consumer product under FTC health-claims constraints, or doing both.
We conduct trademark screening across the complete relevant class set – medical devices, pharmaceuticals, health services, software – rather than performing a surface-level search of the primary class alone, so the shortlist you see has already made it past the collision risk that eliminates names late in the process.
Each name candidate is reviewed against FTC health-claims guidance and given a straightforward read on how FDA or a health system compliance reviewer might interpret it, so you aren't forced to choose between a name you love and one legal will approve. This isn't a legal opinion – final sign-off still belongs to your counsel – but it ensures names arriving at that review have already been screened for obvious claim-language pitfalls.
Once the name is chosen, we create an identity system built to adapt across your real buyer environments: one version that works in a co-branded health system portal alongside an enterprise buyer's brand, and another that competes credibly in a consumer app store or D2C storefront, all built from a unified system rather than two separate identities that simply share a name.
For companies following a defined regulatory path – an FDA submission underway, a clinical validation milestone on the roadmap – we design the naming and identity system to evolve, so a later claims upgrade or category change doesn't require a complete rebrand.
We provide a complete identity system, not merely a logo: name rationale, trademark clearance documentation for final review by your counsel, visual identity guidelines, and a messaging framework reviewed through the same regulatory lens applied to the name.
What separates this from a branding agency is that the regulatory and multi-audience realities of digital health are embedded in the naming and identity work from the first working session, rather than creating a brand identity in isolation and relying on compliance review to identify issues later. We've used this process before with companies navigating this exact clinical-to-consumer, health-system-to-FDA journey.
What we deliver
- Naming brief and candidate generation built around your specific regulatory trajectory and buyer mix
- Trademark pre-screening across medical, pharma, and software classes before formal legal search
- FTC and FDA claims-language review of name and tagline candidates ahead of counsel's final sign-off
- Flexible visual identity system built to hold up in both health system co-branded and consumer app store contexts
A digital health name that passes only a Google search, rather than true trademark clearance and a claims-language review, isn't actually cleared – it simply hasn't been discovered, and that discovery usually comes at the worst time, after the name appears on a contract.
Our Methodology
We deliver naming and identity through a 90-day sprint. During the first 30 days, we develop the naming brief around your regulatory trajectory and buyer mix, create a broad list of candidates, and conduct trademark pre-screening and claims-language review to narrow it to names with a realistic chance of passing formal legal review. From days 30 through 60, the remaining shortlist moves through your legal counsel's formal trademark search alongside early identity exploration, preventing design effort from being spent on a name that ultimately fails to clear. Days 60 through 90 are dedicated to creating the complete identity system for the chosen name – visual identity, messaging framework, and guidelines designed to adapt across enterprise and consumer settings.
Unlike a conventional branding agency process, trademark and regulatory realities guide the work from day one rather than becoming a compliance gate added at the end. We've watched too many digital health companies become attached to a name through a creative-only process, then have legal or FDA regulatory affairs reject it in week ten. Accounting for the constraint from the outset means the name you select is one you can truly keep.
Our Working Process
The first 30 days focus on discovery and candidate development: learning your regulatory trajectory, buyer mix, and current brand equity if you're renaming instead of launching from scratch, then generating names broadly and conducting trademark pre-screening to create a defensible shortlist.
From days 30 through 60, we complete trademark search and claims-language review for the shortlist alongside initial visual identity concepts, so when a name receives legal clearance, the identity direction is already emerging instead of beginning at zero. Your legal counsel must participate in this phase for the formal trademark search, because the sign-off is theirs to provide, not ours.
Days 60 through 90 are spent developing the complete identity system – visual guidelines, messaging framework, and applications for your actual environments, ranging from health system co-branded materials to consumer app store assets. We provide working files and comprehensive documentation, not merely a style guide your team must reverse-engineer.
We meet in a weekly working session throughout the entire 90 days, bringing your legal counsel in specifically for the trademark clearance stage. Most naming and identity engagements are structured as one focused project rather than a continuing retainer, although we often remain involved to support brand rollout as the new identity goes live across your website and sales materials.
- A name that clears trademark search across the relevant medical and software classes
- Naming and messaging that survives FTC and FDA claims-language scrutiny before it ever reaches a regulator
- One identity system that holds up across health system co-branding and consumer-facing contexts
- A brand built to evolve through a future FDA clearance or claims upgrade without a full rebrand
If your digital health company needs naming & identity systems leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a naming and identity engagement cost for a digital health company?
Pricing varies by scope – a complete rename including trademark clearance and an identity system costs more than a naming-only project for a new product line within an established corporate brand. Companies serving both consumer and enterprise audiences generally require more identity system work than a single-audience B2B company.
How much time does the naming and identity process require?
The complete journey from naming brief through finished identity system usually takes the entire 90-day sprint. The timeline may extend if your legal counsel's formal trademark clearance process takes longer than anticipated, which often happens in crowded medical device and pharma classes.
Do you manage the trademark filing itself?
No. We conduct pre-screening to narrow your candidate list to names with a strong likelihood of clearing, while formal trademark search and filing remain the responsibility of your legal counsel.
How does your team collaborate with our legal and regulatory affairs teams?
We work closely together, particularly throughout trademark clearance and claims-language review. We expect your legal counsel to participate from day one, rather than joining at the end to approve a name the team is already attached to, because that is precisely the failure this process is designed to prevent.
How is this different from working with a typical branding agency?
Most branding agencies approach naming and identity as an entirely creative exercise, leaving legal and regulatory review until the final checkpoint. We incorporate regulatory trajectory, trademark exposure, and multi-audience realities from the naming brief onward, so the resulting name and identity can genuinely withstand scrutiny from FDA, FTC, and your own legal counsel.
How is success measured for a naming and identity engagement?
Success means a name that passes formal trademark search, clears your legal team's claims-language review, and an identity system your team can use across enterprise and consumer settings without redesigning it. These are tangible, verifiable results rather than matters of subjective creative taste.
Which type of digital health company is best suited to this service?
Companies rebranding after a funding round, FDA clearance, or category pivot, as well as those introducing a new product line that must serve both health system buyers and consumer audiences. The service suits Series A through Growth-stage digital health companies whose current name poses meaningful legal or market-positioning risk.
